In our cohort of invasive breast cancer patients, TILs represented the 3.78% on average of the tumor mass, FoxP3+ TILs the 0.55%, and occurred with an equal distribution in the tumor center and margin. This evidence concerns the gene FOXP3 and neoplasm.